Trestle Biotherapeutics

San Diego, United States

Trestle Biotherapeutics is a biotechnology company that introduces bioengineered kidneys for patients with kidney disease.

Jun 2023

Grant

Biopharma Biotechnology Life Science Medical Medical Device

Top Investors

Draper AssociatesY CombinatorAcequia Capital (AceCap)Sahin BoydasAsymmetry Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Trestle Biotherapeutics

Who are Trestle Biotherapeutics's investors?

Trestle Biotherapeutics's investors include Draper Associates, Y Combinator, Acequia Capital (AceCap), Sahin Boydas, Asymmetry Ventures.

Where is Trestle Biotherapeutics headquartered?

Trestle Biotherapeutics is headquartered in San Diego, United States.

What does Trestle Biotherapeutics do?

Trestle Biotherapeutics is a biotechnology company that introduces bioengineered kidneys for patients with kidney disease.

What stage is Trestle Biotherapeutics at?

Trestle Biotherapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 12, 2023.

MLA

"Trestle Biotherapeutics — Funding & Investors." VCBacked, June 12, 2023, https://www.vcbacked.co/company/trestle-biotherapeutics. Accessed July 1, 2026.

APA

VCBacked. (2023). Trestle Biotherapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/trestle-biotherapeutics

Wikipedia (cite web)

{{cite web |title=Trestle Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/trestle-biotherapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 12, 2023.